Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
test procedure in accordance with national standard methods

Data source

Reference
Reference Type:
publication
Title:
Chromosomal Aberration Test in CHL/IU Cell
Year:
2000
Bibliographic source:
JAPAN CHEMICAL INDUSTRY ECOLOGY- TOXICOLOGY AND INFORMATION CENTER, JAPAN; MUTAGENICITY TEST DATA OF EXISTING CHEMICAL SUBSTANCES BASED ON THE TOXICITY INVESTIGATION OF THE INDUSTRIAL SAFETY AND HEALTH LAW; (SUPPL. 2), 2000

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: "Standard for Chromosomal Aberration Test in Cultured Mammalian Cells" of the Notification No.652 of the Labour Standards Bureau, Ministry of Labour, Japan
Version / remarks:
September 29, 1997
Deviations:
no
GLP compliance:
no
Type of assay:
in vitro mammalian chromosome aberration test

Test material

Constituent 1
Chemical structure
Reference substance name:
p-phenylenebis(methylamine)
EC Number:
208-719-3
EC Name:
p-phenylenebis(methylamine)
Cas Number:
539-48-0
Molecular formula:
C8H12N2
IUPAC Name:
1,4-Bis(aminomethyl)benzene
Test material form:
solid
Specific details on test material used for the study:
Lot No.: FBX01
Purity: 99.5%

Method

Species / strain
Species / strain / cell type:
other: Chinese hamster lung cells
Details on mammalian cell type (if applicable):
CELLS USED
- Source of cells: supplied by Dr. M. Ishidate, Jr. in 1985
- Modal number of chromosomes: 25
- Doubling time: approximately 15 hours

MEDIA USED
- Type and identity of media including CO2 concentration if applicable: Eagle's MEM supplemented with 10% heat-inactivated (56°C, 30 min) calf serum
Metabolic activation:
with and without
Metabolic activation system:
S9 mix
Test concentrations with justification for top dose:
24 and 48 h treatment: 0.015, 0.03, 0.06, 0.09, 0.12, 0.15 mg/mL
6h treatment: 0.05, 0.1, 0.2, 0.3, 0.4 mg/mL
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: the test substance was soluble in DMSO and insoluble in water.
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
benzo(a)pyrene
Remarks:
with and without S9
Details on test system and experimental conditions:
- Short-period treatment with and without Metabolic Activation (6 hours treatment):
Twenty thousands cells were seeded in culture vessel (with 5 mL of culture medium) and cultured for three days, then culture medium was changed. Cells were simultaneously treated with and without S9 mix and the test substance solution for 6 hours. Then, the test substance mixture was changed to fresh culture medium. After 18 hours further culture, rates of cell growth inhibition were determined.
- Continuous Treatment without Metabolic Activation (24 and 48 hours treatment):
Twenty thousands cells were seeded in a culture vessel (with 5 mL of culture medium), and cultured for three days. Then culture medium was changed and the test substance solution was added to a culture medium. After 24 or 48 hours treatment, rates of cell growth inhibition were determined.

- Determination of Cell Growth Inhibition Rate
The medium was discarded and the cells were washed with physiological saline. Ethanol was added to fix the cells which were then stained with 0.1% crystal violet. After washing and drying, each dish was placed under a cell densitometer to measure the color absorption value (550nm). The cell growth index was calculated with the negative control being 100% and Petri dish without cells being 0%.
- Slide preparation:
Two hours before the end of culture, the cells were treated with 0.2μg/mL Colcemid. After finishing culture, they were dissociated with trypsin (0.1% trypsin + 0.036% EDTA) and centrifuged (1000 rpm, 5 min) to collect cells. After removal of the supernatant, the cells were incubated in a 75 mM hypotonic KCl solution for 20 minutes at 37 °C. The cells were then fixed three times with acetic acid-ethanol (1:3) and spread onto clean glass slides. Each slide was stained with Giemsa solution (2.5% at pH 6.8) for 12 minutes after air-drying.
- Observation:
The number of cells with structural aberrations in 100 well-spread metaphase cells were counted per each culture vessel. The incidence of polyploid cells were recorded simultaneously.
Evaluation criteria:
Negative: frequencies of structural aberrations and of polyploidy less than 5%
Equivocal: frequencies of structural aberrations and of polyploidy from 5% to less than 10%
Positive: frequencies of structural aberrations and of polyploidy 10% or more

Results and discussion

Test results
Key result
Species / strain:
other: Chinese hamster lung cells
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Positive controls validity:
valid

Applicant's summary and conclusion

Conclusions:
Negative result got for test item in chromosomal aberration test in CHL.
Executive summary:

In vitro mammalian chromosome aberration test for test item was performed using lung cells of a newborn Chinese hamster according to "Standard for Chromosomal Aberration Test in Cultured Mammalian Cells" of the Notification No.652 of the Labour Standards Bureau, Ministry of Labour, Japan. The dose level were 0.015, 0.03, 0.06, 0.09, 0.12, 0.15 mg/mL for 24 and 48 h treatment without S9 mix activation, 0.05, 0.1, 0.2, 0.3, 0.4 mg/mL for 6h treatment with and without S9 mix activation. The recovery time forshort-period treatment (6h) was 18 h.

Negative result was given under the test condition.